5-(1-(2-[18F] fluoroethoxy))-[3-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)-propyl]-5,6,7,8-tetrahydronaphthalen
Phase 2 small_molecule active
Quick answer
5-(1-(2-[18F] fluoroethoxy))-[3-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)-propyl]-5,6,7,8-tetrahydronaphthalen for Alzheimers Disease, sporadic Cerebral Amyloid Angiopathy, Parkinson is a Phase 2 program (small_molecule) at Disc Medicine with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Disc Medicine
- Indication
- Alzheimers Disease, sporadic Cerebral Amyloid Angiopathy, Parkinson
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active